Tadeusz Kubicki

Poznan, WP, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?

Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?

Journal: Expert review of hematology

Published: August 05, 2026

Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.

Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.

Journal: The Lancet. Haematology

Published: November 21, 2025

Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma.

Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma.

Journal: British journal of haematology

Published: October 09, 2025

Indicators of an increased risk of therapy-related myeloid neoplasms in lymphoma patients: how can we best evaluate severe impairment of bone marrow function?

Indicators of an increased risk of therapy-related myeloid neoplasms in lymphoma patients: how can we best evaluate severe impairment of bone marrow function?

Journal: Expert review of hematology

Published: August 08, 2025

Carfilzomib resistance in multiple myeloma: A comparative metabolomic analysis.

Carfilzomib resistance in multiple myeloma: A comparative metabolomic analysis.

Journal: Journal of applied genetics

Published: July 08, 2025

Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant.

Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant.

Journal: HemaSphere

Published: March 21, 2025

Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma.

Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma.

Journal: Blood neoplasia

Published: March 17, 2025

Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.

Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.

Journal: Leukemia

Published: March 07, 2025

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).

Journal: Blood cancer journal

Published: June 26, 2024

T-cell exhaustion in multiple myeloma.

T-cell exhaustion in multiple myeloma.

Journal: Expert review of hematology

Published: June 26, 2024

Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone.

Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone.

Journal: Polish archives of internal medicine

Published: May 15, 2024

Distinguishing Daratumumab from Endogenous Monoclonal Proteins in Serum from Multiple Myeloma Patients Using an Automated Mass Spectrometry System.

Distinguishing Daratumumab from Endogenous Monoclonal Proteins in Serum from Multiple Myeloma Patients Using an Automated Mass Spectrometry System.

Journal: The journal of applied laboratory medicine

Published: April 19, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026